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INTRODUCTION  
Animal models and human studies suggest that osteocytes regulate the skeleton’s response to 
mechanical unloading at the cellular level in part by an increase in sclerostin, an inhibitor of the 
anabolic Wnt pathway. However, few studies have reported changes in serum sclerostin in 
humans exposed to reduced mechanical loading. Thus, we determined changes in serum 
sclerostin and bone turnover markers in healthy adult men who participated in a controlled bed 
rest study.  
METHODS 
Seven healthy adult men (31 ± 3 yrs old) underwent 90-day six-degree head down tilt bed rest at 
the University of Texas Medical Branch in Galveston's Institute for Translational Sciences - 
Clinical Research Center (ITS-CRC). Serum sclerostin, PTH, serum markers of bone turnover 
(bone specific alkaline phosphatase, RANKL/OPG, and osteocalcin), urinary calcium and 
phosphorus excretion, and 24 hour pooled urinary markers of bone resorption (NTX, DPD, PYD) 
were evaluated pre-bed rest (BL), bed rest day 28 (BR-28), bed rest day 60 (BR-60), and bed rest 
day 90 (BR-90). In addition, bone mineral density (BMD) was assessed by dual-energy X-ray 
absorptiometry (DXA) at BL, BR-60, and post bed rest day 5 (BR+5). Data are reported as mean 
± standard deviation.  We used repeated measures ANOVA to compare baseline values to BR-28, 
BR-60, and BR-90.   
RESULTS 
Consistent with prior reports, BMD declined significantly (1-2% per month) at weight-bearing 
skeletal sites (spine, hip, femur neck, and calcaneus). Serum sclerostin levels were elevated above 
BL at BR-28  (+29% ± 20%, p = 0.003), BR-60 (+42% ± 31%, p < 0.001), and BR-90 (22% ± 
21%, p = 0.07). Serum PTH levels were reduced at BR-28 (-17% ± 16%, p = 0.02), BR-60 (-24% 
± 14%, p = 0.03), and returned to baseline at BR-90 (-21% ± 21%, p = 0.14). Serum bone 
turnover markers did not change, however urinary bone resorption markers and calcium were 
significantly elevated following bed rest (p < 0.01).   
CONCLUSION 
We observed an increase of serum sclerostin associated with decreased serum PTH and elevated 
bone resorption markers in otherwise healthy men subjected to long-term immobilization.   
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